Objectives: There has been speculation that women with oestrogen-related ca
ncers have been exposed to high levels of oestrogen in earlier life and the
refore also during their pregnancies prior to the disease. For this reason
we examined signs of reproductive outcome related to oestrogen exposure suc
h as twinning, sex ratio, birth weight and congenital malformation in women
who later were diagnosed with breast cancer, endometrial or ovarian cancer
.
Methods: For 5213 children born to women who later developed breast cancer,
557 children born to women who later developed ovarian cancer and 173 chil
dren born to mothers with endometrial cancers we selected as a control four
times as many newborns of mothers without these cancers after matching for
mothers' parity, age, date of birth and hospital attended. All data were e
xtracted from existing nationwide files. Most of the women's reproductive l
ives fell within the period of the birth registry from 1973 to 1993.
Results: No differences in sex ratio, birth weight or malformation were fou
nd between the newborns to cancer or control mothers in any of the cancer g
roups studied. The only significant findings were less than expected births
of twins to mothers who later developed cancer of the ovaries and a higher
proportion of newborns with a birth weight over 4000 g in the cancer corpu
s uterus group.
Conclusion: Although the amount of information is limited for endometrial a
nd ovarian cancers, we found no strong indication of elevated oestrogen lev
els during pregnancy.